Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis
Clinical trial NCT04088721 · COMPLETED
Trial details
- NCT number
- NCT04088721
- Sponsor
- Advagene Biopharma Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2020-07-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.